-
Endometrial and other primary cancers after tamoxifen treatment of breast cancer - results of retrospective cohort studyUršič-Vrščaj, Marjetka, 1952-2012 ...Objectives: The aim of the retrospective cohort study was to evaluate the relationship between the influence of tamoxifen on the development of endometrial and other second primary cancers in the ... patients with invasive breast cancer. Study Design: A cohort of 630 women diagnosed with breast cancer from 1987 to 1994 was selected from a population-based registry; 440 patients were treated with tamoxifen and 190 patients without it. The observation period was 8.5 years (range 5-12 years). The data were analysed bythe relative risk (RR) calculation at a confidence interval (CI) of 95%, using a Mantel-Haenszel chi(2)-test and Fisher's p-test to evaluate statistical significance. Results: There were no statistically significant differences between the group of breast cancer patients treated with tamoxifenand without it as regards the age at the breast cancer diagnosis, family medical histories, body mass, age at menopause, fertility, diabetes, hormone replacement therapy and oestrogen-hormone replacement therapy. In 41/440 (9.3%) tamoxifen-treated patients and in 8/190 (4.2%) non-users of tamoxifen, diagnostic curettage was performed due to benign endometrial changes and endometrial cancer (EC). The difference in the proportions of patients with diagnostic curettage in both group was statistically significant(chi(2)=4.45, p=0.03). In the group of patients treated with tamoxifen, with the median treatment duration of 40 months (range 1-97 months)and in the group of patients without tamoxifen, EC was diagnosed in 11 and in two patients, respectively. The evaluated RR was 2.38 (0.53-10.61, 95% CI). (Abstract truncated at 2000 characters).Source: European Journal of Obstetrics, Gynecology and Reproductive Biology. - ISSN 0301-2115 (Letn. 95, št. 1, 2001, str. 105-110)Type of material - article, component partPublish date - 2001Language - englishCOBISS.SI-ID - 13298649
Author
Uršič-Vrščaj, Marjetka, 1952-2012 |
Kovačič, Julij, zdravnik ginekolog, 1922- |
Bebar, Sonja |
Djurišić, Astrid |
Fras, Albert-Peter, 1943-2025 |
Robič, Vesna
Topics
Breast neoplasms |
Drug therapy |
Tamoxifen |
Therapeutic use |
Adverse effects |
Endometrial neoplasms |
Neoplasms, second primary |
Cohort studies |
Retrospective studies |
Age factors
Shelf entry
Permalink
- URL:
Impact factor
Access to the JCR database is permitted only to users from Slovenia. Your current IP address is not on the list of IP addresses with access permission, and authentication with the relevant AAI accout is required.
| Year | Impact factor | Edition | Category | Classification | ||||
|---|---|---|---|---|---|---|---|---|
| JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP | |
Impact factor
Select the library membership card:
DRS, in which the journal is indexed
| Database name | Field | Year |
|---|
| Links to authors' personal bibliographies | Links to information on researchers in the SICRIS system |
|---|---|
| Uršič-Vrščaj, Marjetka, 1952-2012 | 09764 |
| Kovačič, Julij, zdravnik ginekolog, 1922- | 01512 |
| Bebar, Sonja | 17170 |
| Djurišić, Astrid | 21834 |
| Fras, Albert-Peter, 1943-2025 | 02687 |
| Robič, Vesna | 17174 |
Select pickup location:
Material pickup by post
Notification
Subject headings in COBISS General List of Subject Headings
Select pickup location
| Pickup location | Material status | Reservation |
|---|
Please wait a moment.